Smart Drug Development & Design from Candidate to Phase I
When: April 4 I 9:30am – 2:15pm
Where: Conference Center Technology Park, Im Neuenheimer Feld 582, Heidelberg
This event will focus on key considerations for transitioning a molecule from discovery to phase 1 readiness including API and formulation development, pharmacokinetics, quality and CMC requirements, and incorporation of clinical supply services solutions to meet protocol, clinical site and patient needs.
The event is free of charge but a registration is required.
Following the meeting, all Catalent speakers and executives will be available for private, no-obligation discussions on specific programmes and challenges. To request an appointment, please contact Annalisa Zuccotti (email@example.com).
Neueste Artikel von Eva (alle ansehen)
- Smart Drug Development & Design from Candidate to Phase I - 2. April 2019
- Startup BW Summit 2019 - 17. Januar 2019